within Pharmacolibrary.Drugs.ATC.C;

model C02DB02_1
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00016666666666666666,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C02DB02_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydralazine is a vasodilator used primarily to treat hypertension and congestive heart failure. It acts by directly relaxing vascular smooth muscle, leading to decreased peripheral resistance. Hydralazine is still approved and used clinically, often as adjunct therapy or when first-line antihypertensive agents are unsuitable.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from intravenous administration in healthy adults.</p><h4>References</h4><ol><li><p>Chera-Aree, P, et al., &amp; Wataganara, T (2020). Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women. <i>Journal of clinical pharmacology</i> 60(12) 1662–1670. DOI:<a href=\"https://doi.org/10.1002/jcph.1685\">10.1002/jcph.1685</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32598488/\">https://pubmed.ncbi.nlm.nih.gov/32598488</a></p></li><li><p>Ludden, TM, et al., &amp; Lin, MS (1980). Hydralazine kinetics in hypertensive patients after intravenous administration. <i>Clinical pharmacology and therapeutics</i> 28(6) 736–742. DOI:<a href=\"https://doi.org/10.1038/clpt.1980.229\">10.1038/clpt.1980.229</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7438689/\">https://pubmed.ncbi.nlm.nih.gov/7438689</a></p></li><li><p>Iwaki, M, et al., &amp; Ito, Y (1989). Pharmacokinetics and biotransformation of hydralazine acetone hydrazone, a metabolite of hydralazine, in the rat. <i>Journal of pharmaceutical sciences</i> 78(10) 867–873. DOI:<a href=\"https://doi.org/10.1002/jps.2600781018\">10.1002/jps.2600781018</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2600796/\">https://pubmed.ncbi.nlm.nih.gov/2600796</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C02DB02_1;
